Literature DB >> 14745525

Issues specific to implementing PET-CT for pediatric oncology: what we have learned along the way.

Sue C Kaste1.   

Abstract

In parallel with the expansion of PET imaging to pediatric patients has been the technological development of merging state-of-the-art cross-sectional anatomic information (CT) with functional imaging (PET) into a single modality: PET-CT. Attending to the clinical, scheduling, and medical needs that are unique to imaging children and adolescents can be a challenge, particularly when instituting a single new modality. When that modality bridges two unique, previously independent methods-often previously located in two separate departmental divisions-the details and logistics required to set up a smoothly functioning process can be particularly difficult. This paper focuses on our experience in implementing PET-CT in a tertiary pediatric referral center.

Entities:  

Mesh:

Year:  2004        PMID: 14745525     DOI: 10.1007/s00247-003-1111-6

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  14 in total

1.  Positron emission tomography and PET CT of the head and neck: FDG uptake in normal anatomy, in benign lesions, and in changes resulting from treatment.

Authors:  Gerhard W Goerres; Gustav K Von Schulthess; Thomas F Hany
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

2.  Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET.

Authors:  H E Daldrup-Link; C Franzius; T M Link; D Laukamp; J Sciuk; H Jürgens; O Schober; E J Rummeny
Journal:  AJR Am J Roentgenol       Date:  2001-07       Impact factor: 3.959

3.  Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.

Authors:  Miriam A Bredella; Gary R Caputo; Lynne S Steinbach
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

4.  FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy.

Authors:  C Franzius; J Sciuk; H E Daldrup-Link; H Jürgens; O Schober
Journal:  Eur J Nucl Med       Date:  2000-09

Review 5.  Clinical role of FDG PET in evaluation of cancer patients.

Authors:  Lale Kostakoglu; Harry Agress; Stanley J Goldsmith
Journal:  Radiographics       Date:  2003 Mar-Apr       Impact factor: 5.333

6.  Whole-body positron emission tomography in patients with HIV-1 infection.

Authors:  Alexander M Scharko; Scott B Perlman; Robert W Pyzalski; Franklin M Graziano; James Sosman; C David Pauza
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

7.  Anatomical loci of HIV-associated immune activation and association with viraemia.

Authors:  Sujatha Iyengar; Bennett Chin; Joseph B Margolick; Beulah P Sabundayo; David H Schwartz
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

8.  Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography.

Authors:  Douglas S Hawkins; Joseph G Rajendran; Ernest U Conrad; James D Bruckner; Janet F Eary
Journal:  Cancer       Date:  2002-06-15       Impact factor: 6.860

9.  Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.

Authors:  B L Shulkin; R J Hutchinson; V P Castle; G A Yanik; B Shapiro; J C Sisson
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

Review 10.  PET imaging of osteosarcoma.

Authors:  Winfried Brenner; Karl H Bohuslavizki; Janet F Eary
Journal:  J Nucl Med       Date:  2003-06       Impact factor: 10.057

View more
  10 in total

1.  Is PET/CT necessary in paediatric oncology? Against.

Authors:  K Hahn; T Pfluger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

2.  Is PET/CT necessary in paediatric oncology? For.

Authors:  Christiane Franzius; Kai Uwe Juergens; Otmar Schober
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-08       Impact factor: 9.236

Review 3.  PET/CT in paediatric oncology: indications and pitfalls.

Authors:  Christiane Franzius; Kai Uwe Juergens
Journal:  Pediatr Radiol       Date:  2009-06

Review 4.  18F-PET-CT in extracranial paediatric oncology: when and for whom is it useful?

Authors:  Sue C Kaste
Journal:  Pediatr Radiol       Date:  2008-06

5.  PET imaging in pediatric neuroradiology: current and future applications.

Authors:  Sunhee Kim; Noriko Salamon; Hollie A Jackson; Stefan Blüml; Ashok Panigrahy
Journal:  Pediatr Radiol       Date:  2009-11-24

Review 6.  2-deoxy-2-((18)F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology.

Authors:  John Freebody; Eva A Wegner; Monica A Rossleigh
Journal:  World J Radiol       Date:  2014-10-28

Review 7.  18F-FDG-avid sites mimicking active disease in pediatric Hodgkin's.

Authors:  Sue C Kaste; Scott C Howard; Elizabeth B McCarville; Matthew J Krasin; Philip G Kogos; Melissa M Hudson
Journal:  Pediatr Radiol       Date:  2004-11-16

Review 8.  Nuclear medicine and multimodality imaging of pediatric neuroblastoma.

Authors:  Wolfgang Peter Mueller; Eva Coppenrath; Thomas Pfluger
Journal:  Pediatr Radiol       Date:  2012-11-14

9.  Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology.

Authors:  J Stauss; C Franzius; T Pfluger; K U Juergens; L Biassoni; J Begent; R Kluge; H Amthauer; T Voelker; L Højgaard; S Barrington; S Hain; T Lynch; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

10.  Patient-adapted organ absorbed dose and effective dose estimates in pediatric 18F-FDG positron emission tomography/computed tomography studies.

Authors:  Brian M Quinn; Yiming Gao; Usman Mahmood; Neeta Pandit-Taskar; Gerald Behr; Pat Zanzonico; Lawrence T Dauer
Journal:  BMC Med Imaging       Date:  2020-01-29       Impact factor: 1.930

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.